To describe the natural history of frailty transitions in a large cohort of community-dwelling older men and identify predictors associated with progression to or improvement from states of greater frailty. DESIGN: Prospective cohort study. SETTING: Six U.S. sites. PARTICIPANTS: Community-dwelling men aged 65 and older (N = 5,086). MEASUREMENTS: Frailty was measured at baseline and an average of 4.6 years later. Frailty was defined as having three or more of the following components (low lean mass, weakness, self-reported exhaustion, low activity level, and slow walking speed); prefrailty was defined as having one or two components. Separate multivariable logistic regression models were analyzed for progression and improvement in frailty status. RESULTS: Of the 5,086 men, 8% were frail, 46% were prefrail, and 46% were robust at baseline. Between baseline and follow-up, 35% progressed in frailty status or died, 56% had no change in frailty status, and 15% of prefrail or frail participants improved, although only 0.5% improved across two levels, from frail to robust. In multivariable models, factors associated with improvement in frailty status included greater leg power, being married, and good or excellent self-reported health, whereas presence of any instrumental activity of daily living (IADL) limitations, low albumin levels, high interleukin-6 levels, and presence of chronic obstructive pulmonary disease or diabetes mellitus were associated with lower likelihood of improvement in frailty status. CONCLUSION: Improvement in frailty status was possible in this cohort of community-dwelling older men, but improvement from frail to robust was rare. Several predictors were identified as possible targets for intervention, including prevention and management of comorbid medical conditions, prevention of IADL disability, physical exercise, and nutritional and social support.
F railty has been proposed as a geriatric syndrome due to multisystem dysregulation that results in decreased physiological reserve, conferring vulnerability to adverse outcomes. 1 A validated phenotype of frailty has been shown to predict incident and worsening disability, hospitalization, falls, fractures, and mortality. 2, 3 Few studies have examined the natural history and precipitants of frailty transitions over time. One study reported that progression in frailty status was more common than improvement in frailty status in 754 community-dwelling adults aged 70 and older over 4.5 years in the longitudinal Precipitating Events Project cohort. 4 Another study demonstrated comparable trends in frailty status transitions and identified diabetes mellitus (DM) with macrovascular complications, less education, and longer follow-up as predictors of progression in frailty status. 5 In both studies, a small but significant proportion of participants (9-14%) improved in frailty status. These results suggest that frailty is a dynamic process and that prevention or reversal of frailty may be possible, but a comprehensive evaluation of potential behavioral, clinical, socioeconomic, and physiological predictors of transitions in frailty status has not been conducted in a large cohort of community-dwelling older adults.
Identifying modifiable factors may provide insights into mechanisms of frailty and facilitate development of interventions to delay or reverse its progress. Greater understanding of characteristics associated with improvement in frailty status and knowledge of early risk factors could allow for identification of older adults most likely to benefit from targeted interventions. The objectives of this study were to determine patterns and probability of frailty progression and improvement over time and identify predictors of transitions in frailty status.
METHODS

Participants
Between 5 ,229 men participated in a second visit (V2). For these analyses, 143 men who were missing frailty measurements at either visit and were still alive were excluded, leaving 5,086 men to examine the transition between V1 and V2 ( Figure S1 ). Written informed consent was obtained from each participant, and the institutional review boards at each institution approved the study.
Frailty and Frailty Transitions
Frailty status at baseline was defined using criteria similar to those of Fried and colleagues 2 :
• Shrinking: lowest quintile of appendicular lean mass (ALM) (adjusted for height and total body fat) • Weakness: lowest quintile of grip strength stratified according to body mass index (BMI) quartiles • Exhaustion: response of "a little or none" to the question, "How much of the time during the past 4 weeks did you have a lot of energy?" from the Medical Outcomes Study 12-item Short Form Survey (SF-12) 8 • Slowness: lowest quintile of 6-m walk speed stratified according to standing height (median) • Low physical activity: lowest quintile of Physical Activity Scale for the Elderly (PASE) score 9 Men meeting none of the above criteria were considered to be robust; those meeting one or two criteria were considered to be prefrail, and those meeting three or more criteria were considered to be frail. To jointly analyze the outcomes of frailty status at V2 and mortality between V1 and V2, four levels of frailty status were considered at V2: robust, prefrail, frail, and dead. Participants who were not frail at V1 and prefrail or frail at V2, were prefrail at V1 and frail at V2, or died between visits were considered to have progressed in frailty status. Participants who were prefrail at V1 and robust at V2 or frail at V1 and prefrail or robust at V2 were considered to have improved in frailty status.
Measurements
All participants completed a standard self-administered questionnaire that included questions about race and ethnicity, education, marital status, subjective socioeconomic status compared with the community, 10 smoking, alcohol, self-reported disease, and self-rated health. The Teng Modified Mini-Mental State Examination (3MS) was used to assess cognitive function. Instrumental activities of daily living (IADLs) and activities of daily living (ADLs) were assessed using a self-administered questionnaire. Physiological parameters included leg power; ability to perform chair stands; and fasting serum glucose, creatinine, and albumin. Inflammatory markers C-reactive protein (CRP), interleukin-10 (IL-10), and tumor necrosis factor (TNF) were evaluated in a subset of 950 participants. The questionnaires and a description of the measurements of physiological parameters are further described in Appendix S1.
Statistical Analysis
Based on knowledge of the pathogenesis of frailty, it was hypothesized that the following variables would be associated with frailty transitions: comorbidities, sociodemographic characteristics, physical function, lifestyle, and blood markers of inflammation or organ dysfunction. 5, [11] [12] [13] [14] To assess systemic inflammation, a composite inflammatory burden score was calculated, as has been done previously with this dataset. 15 Variables included within each category are listed in the Appendix S1. Participant characteristics were compared across transitions in frailty status using analysis of variance for normally distributed continuous variables, the Kruskal-Wallis test for nonnormal continuous variables, and chi-square tests for categorical variables. Progression outcomes included three transitions (robust to prefrail, frail, or death; prefrail to frail or death; frail to death) and improvement outcomes included two transitions (prefrail to robust, frail to prefrail or robust). All variables significant at P < .05 for each outcome in age-and siteadjusted models were added to multivariable models according to category. Multicollinearity was tested for within each category using the variance inflation factor, with values greater than 3 considered positive for multicollinearity. Variables that remained significant in multivariable models at P < .05 were subsequently added to final models for each outcome. Inflammatory cytokine variables were entered into separate models given that not all participants (n = 950) underwent additional testing. Age and site were forced into all models. A post hoc sensitivity analysis was performed using the same multivariable models, excluding men who died. All analyses were conducted using SAS version 9.2 (SAS Institute, Inc., Cary, NC).
RESULTS
At V1, men had a mean age of 73.4 AE 5.8 and a mean BMI of 27.4 AE 3.8 kg/m 2 ( Table 1) ; 83% were married, 55% were college educated, 44% reported high socioeconomic status compared with the community, and 59% reported past smoking, but only 3% reported currently smoking. Nearly 70% reported one or more medical conditions; the most commonly reported conditions were hypertension (42%) and cancer (29%). Eighty-one percent had no IADL limitations. At V1, nearly 8% of participants met the criteria for frailty, and another 46% met the criteria for prefrailty. In frail participants, the most-prevalent frailty criteria were weakness, slowness, and low activity; exhaustion was the least prevalent (Table S1 ). Frail men were more likely to report IADL limitations (59%) than prefrail (23%) and robust men (9%), to report more than one medical condition (85%, 72%, and 61%, respectively), and to demonstrate cognitive dysfunction (11%, 5%, and 3%, respectively) ( Table 1) .
Frailty Transitions
Over an average of 4.6 years, the proportion of frail men increased, and the proportion of robust men decreased ( Figure 1 , Table S2 ). Of the 5,086 men with frailty measures at both visits, 1,791 (35%) progressed in frailty status or died (1,223 (26%) robust or prefrail men progressed; 568 (11%) of all men died), 2,872 (56%) had no change in frailty status, and 423 (15%) of prefrail or frail participants improved in frailty status.
The probabilities of each frailty transition are displayed in Figure 1 . For all participants, regardless of V1 frailty status, the most likely outcome at V2 was no change in frailty status (0.60 for robust participants, 0.55 for pre-frail participants, and 0.45 for frail participants). The most-frequent frailty transitions were from robust to prefrail (0.32) and from frail to death (0.28). Not all of the transitions were progressive; some participants improved in frailty status. The probability of improving from frail to prefrail was 0.16 and of improving from prefrail to robust was 0.15. These probabilities were similar to that of transitioning from prefrail to frail (0.17). Transitions between one frailty state and the next were more common than transitions across two frailty states. The probability of transitioning from prefrail to death was 0.12, and the probability of improving across two states, from frail to robust, was 0.005 ( Figure 1) .
Characteristics of participants according to frailty status transition are presented in Tables S3 and S4 . Participants who improved in frailty status were younger, reported higher socioeconomic status, were more likely to be married, had stronger leg power, and reported fewer medical conditions and IADL limitations at V1. In the 352 participants who improved from prefrail at V1 to robust at V2, the most prevalent improvements in individual frailty criteria were reversal of low physical activity and slowness, with 37% and 28%, respectively, meeting each of these criteria at V1 but not at V2. In the 69 participants who improved from frail at V1 to prefrail at V2, the mostprevalent improvements in individual frailty criteria were reversal of low physical activity, exhaustion, and slowness, with 45%, 36%, and 34%, respectively, meeting each of these criteria at V1 but not V2 (Table S5) .
Age-and Site-Adjusted Predictors of Improvement and Progression in Frailty State
Many predictors were statistically significant in age-and site-adjusted regression models (Table S6 ). Predictors associated with improvement in frailty status included being married, good or excellent self-reported health, ability to complete chair stands, and greater leg power. Men with two or more comorbidities (specifically chronic obstructive pulmonary disease (COPD), DM, or congestive heart failure (CHF)), albumin less than 4 g/dL, fasting glucose greater than 26 mg/dL, CRP or IL-6 levels in the highest quartile, or any IADL limitations were less likely to improve from prefrail or frail states. Predictors associated with progression in frailty status included past or current smoking, one or more comorbidities (specifically hypertension, CHF, COPD, cancer, stroke, osteoporosis), CRP or TNF-a levels in the highest quartile, albumin less than 4 g/dL, fasting glucose greater than 26 mg/dL, any IADL limitations, and cognitive dysfunction. Men who were non-Hispanic white or college educated, reported high socioeconomic status, or had greater leg power were less likely to transition to prefrail or frail states.
Multivariable Predictors for Improvement or Progression in Frailty State
There was no evidence of multicollinearity among variables within each category. Results from final multivariable logistic regression models for progression and improvement in frailty status are presented in Tables 2  and 3 , respectively. Variables associated with progression in frailty status included a diagnosis of DM, CHF, or cancer; cognitive dysfunction; current smoking; CRP or TNF-a levels in the highest quartile; albumin less than 4 g/ dL; and any IADL limitations. Greater leg power, college education, and good or excellent self-reported health were associated with lower likelihood of progression in frailty.
Men with DM were nearly three times as likely to progress in frailty status from robust (odds ratio (OR) = 2.7, 95% CI = 1.7-4.3). A diagnosis of DM, current smoking, any IADL limitation, and greater leg power retained similar strengths of association with progression outcomes in sensitivity analyses excluding men who died. Greater leg power, being married, and good or excellent self-reported health were associated with improvement in frailty status. In particular, being married was associated with a likelihood of improving from the frail state that was 3.6 times as great (OR = 3.6, 95% CI = 1.1-11.7). IL-6 level in the highest quartile was associated with lower likelihood of improvement from prefrail to robust, whereas presence of any IADL limitation, DM, COPD, and albumin level less than 4 g/dL were associated with less likelihood of improvement from frail to prefrail or robust. With the exception of good or excellent selfreported health, which dropped out, all variables retained similar strengths of association with improvement outcomes in sensitivity analyses excluding men who died.
DISCUSSION
These findings demonstrate that frailty was dynamic in older community-dwelling MrOS participants over approximately 5 years; 35% of the cohort progressed in frailty status or died, 56% had no change in frailty status, and 15% of prefrail or frail participants improved. Improvement in frailty occurred in a significant proportion of men, indicating that prefrailty and frailty are not irreversible, although improvement across two states, from frail to robust, was extremely rare. Variables associated with progression differed from variables associated with improvement in frailty, with some variables (e.g., smoking, CHF, cancer) significantly associated with progression or improvement between one but not all stages along the frailty pathway, suggesting that different factors may play a role in the initiation, progression, and reversal of frailty.
The development and progression of frailty is thought to be associated mechanistically with a systemic inflammatory state and neuroendocrine dysregulation. 16, 17 Poor nutrition is also implicated, with diet quality previously shown to be inversely associated with prevalent and future frailty status in the MrOS cohort. 17 Predictors of frailty transitions identified in the multivariate models were consistent with current understanding of likely causal pathways. Men with high levels of inflammatory markers were more likely to progress in frailty (CRP in highest quartile) and less likely to improve (IL-6 in the highest quartile). Low albumin levels were associated with lower likelihood of improving from the frail state. Factors directly related to functional ability, such as IADL limitations, selfreported health, and leg power, reflect downstream effects of convergent, multisystem physiological processes and explained a significant degree of variance in frailty transition outcomes. Finally, certain populations, particularly those with DM or COPD and smokers, may be at particularly high risk of progression in frailty and unlikely to improve, and men who are married are more likely to improve. DM and COPD have been shown to be associated with frailty. 5, 18 Frailty has been identified as a useful prognostic indicator of mortality in individuals with these 
The effect estimates (ORs) for all continuous variables were expressed per standard deviation increment, except age, which was expressed per 1-year increment. For continuous variables, odds ratios refer to increments of one standard deviation.
a Adjusted for age and site. conditions. 19, 20 The current results are novel in that they identify COPD and DM as predictive of progression in frailty status and lower likelihood of improvement. The link between DM and sarcopenia is well known; muscle mass and muscle quality appear to be lower in older adults with diabetes mellitus. 21 There is evidence to suggest that DM adversely affects skeletal muscle through direct glucose toxicity, activation of protein degradation pathways due to insulin resistance, reduction in motor neurons, and contributions to the inflammatory-catabolic milieu. 21, 22 COPD and frailty have overlapping pathophysiological features as well; prior studies have demonstrated that systemic inflammatory changes, oxidative stress, high basal metabolic rate leading to unexplained weight loss, and loss of skeletal muscle mass accompany the lung inflammatory response in COPD. 23 Thus, the two conditions may compound one another. Beyond increasing general awareness of clinicians that frail older adults with comorbid COPD or DM are a particularly high-risk group, future research should evaluate potential interventions in these patients with the goal of reducing frailty-related adverse outcomes.
The protective effects of close personal relationships and, conversely, the negative health outcomes associated with social isolation are well known. 24, 25 Associations have been demonstrated between marital status and morbidity and mortality, 25, 26 with the protective effect of marriage more pronounced in men than in women. 27 Marital interaction studies demonstrate physiological changes in cardiovascular, neuroendocrine, and immune pathways in response to social interactions between study participants and their spouses, 28 but few prior studies have investigated the link between marital status and frailty. In one study, marital status was shown to be associated with onset of frailty in older adults. 29 The current results add to this emerging area of research by demonstrating that the likelihood of improvement from frail to prefrail or robust is four times as great in married participants. This finding highlights the importance of considering social support in research efforts to reverse frailty through targeted interventions; future studies may choose to evaluate whether interventions with supervised or group components are more beneficial for older adults with limited social support.
Finally, leg power was a significant predictor of all frailty state transition outcomes. Consistent with these findings, a secondary analysis of results from the Increased Velocity Exercise Specific to Task (InVEST) trial, a multicenter, randomized clinical trial comparing two rehabilitative exercise programs in community-dwelling adults with mobility limitations, found that leg power was the optimal rehabilitative impairment target, because changes in leg power were associated with clinically meaningful differences in gait speed and Short Physical Performance Battery scores. 30 Long-term complications of DM may result in losses in muscle quality, function, and mass, but gains in leg power may be achieved with targeted training interventions in this group as well. 31 Limitations of this study include use of a single-sex and predominantly non-Hispanic white cohort, the possibility of missed transitions over short intervals, the possibility of incidental fluctuations in frailty score over short time periods, inability to capture trends in frailty transitions occurring over longer time periods, and little information regarding acute precipitants that may have contributed to progression in frailty. Future studies should examine more-vulnerable populations of older adults, such as those in assisted living or who are homebound or in a nursing home, with higher levels of disability. It may also be beneficial to perform subgroup analyses of transitions occurring acutely over shorter intervals, because it is likely that such transitions reflect distinct physiological processes.
In conclusion, these results demonstrate that improvement in frailty status in older community-dwelling adults is possible and is associated with social, functional, and clinical factors, although complete recovery from frailty is rare. Future studies should evaluate targeted interventions in frail and prefrail older adults because these results suggest that the likelihood of improvement is similar from both baseline states. Effective strategies might address predictors of improvement and progression in frailty, including preservation of functional ability through interventions that target strength and lower-extremity power, improved management of comorbid medical conditions such as DM and COPD, and social and nutritional support.
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